ZIM
MD icon

Zacks Investment Management’s Pediatrix Medical MD Stock Holding History

Zacks Investment Management’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.76M Buy
109,134
+9,523
+10% +$217K 0.02% 331
2026
Q1 		$2.13M Buy
99,611
+15,832
+19% +$330K 0.02% 338
2025
Q4 		$1.79M Sell
83,779
-5,898
-7% -$121K 0.01% 364
2025
Q3 		$1.5M Buy
+89,677
New +$1.34M 0.01% 366
2022
Q4 		– Sell
-40,840
Closed -$674K – 639
2022
Q3 		$674K Sell
40,840
-1,123
-3% -$22.6K 0.01% 394
2022
Q2 		$882K Buy
41,963
+26,180
+166% +$534K 0.01% 352
2022
Q1 		$371K Buy
+15,783
New +$386K 0.01% 487
2018
Q3 		– Sell
-27,380
Closed -$1.19M – 576
2018
Q2 		$1.19M Sell
27,380
-1,476
-5% -$70.7K 0.03% 387
2018
Q1 		$1.6M Buy
+28,856
New +$1.58M 0.04% 317
2016
Q1 		– Sell
-3,301
Closed -$237K – 652
2015
Q4 		$237K Sell
3,301
-1,237
-27% -$91.5K 0.01% 494
2015
Q3 		$349K Buy
+4,538
New +$366K 0.01% 486

Other funds holding MD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Zacks Investment Management's MD Position: Q2 2026 in Review

Zacks Investment Management increased its Pediatrix Medical (MD) stake by 9.6% in Q2 2026, buying an estimated $217K and bringing the position to 109,134 shares worth $2.76M. The position accounts for 0.02% of the portfolio, ranked #331.

Zacks Investment Management first reported a position in MD in Q3 2015 and has held it in 11 quarters since. 304 funds tracked by Wall St. Rank hold MD as of Q2 2026.

  • Zacks Investment Management held 109,134 shares of Pediatrix Medical worth $2.76M as of Q2 2026.
  • Zacks Investment Management bought 9,523 Pediatrix Medical shares in Q2 2026, an estimated $217K.
  • Pediatrix Medical made up 0.02% of Zacks Investment Management's portfolio in Q2 2026, its #331 holding.
  • Zacks Investment Management first reported a position in Pediatrix Medical in Q3 2015 and has held it in 11 quarters since.
  • 304 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2026.

Based on Zacks Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.